insightful comments regarding our paper [1]. Equating 5-year survival rate with 5-year cure rate [2] ignores the literature on delayed (greater than 5 years) recurrence of a primary tumor. However, we believe that most clinicians use 5-year survival rates as they were intended to be used: to estimat
Potential doubling time and tumour doubling time in meningiomas and neurinomas
β Scribed by S. Nakasu; Y. Nakasu; M. Nakajima; M. Yokoyama; M. Matsuda; J. Handa
- Publisher
- Springer Vienna
- Year
- 1996
- Tongue
- English
- Weight
- 710 KB
- Volume
- 138
- Category
- Article
- ISSN
- 0001-6268
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The in vivo infusion of Bromodeoxyuridine (BrdUrd), followed by delayed biopsy and bivariate DNA-BrdUrd flow cytometry, allows the potential doubling time (T pot ) of human tumors to be estimated. According to Steel, the mathematical definition of T pot is T pot β«Ψβ¬ ln 2/K p , where K p is the rate
To assess the clinical implications of the tumor volume doubling time of gastric smooth muscle tumors based on a comparison with the histologic findings, seven tumors (four leiomyomas and three leiomyosarcomas) were followed up by consecutive upper gastrointestinal studies between March 1985 and Dec